Fig. 1From: A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapiesSystematic review flow diagram. The final studies included 25 disease cost studies (evaluate direct and/or indirect costs associated with ILD) and 7 cost effectiveness analyses (compare costs and outcomes of 2 or more interventions). Abbreviations: WOS, Web of ScienceBack to article page